Skip to main content

Smith & Wesson Brands, Inc. (SWBI) Stock Forecast

Data as of May 2, 2026

Industrials · Current price $15.58 (+0.26%)

Consensus Target
$15.25
Upside
-2.1%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $12.50Consensus $15.25High $18.00
▲ Current $15.58

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Jun 21, 2024Mark SmithLake Street$18.00+15.5%

SWBI vs Sector & Market

MetricSWBIIndustrials AvgLarge Cap Avg
Analyst Rating2.002.412.41
Analyst Count1818
Target Upside-2.1%+85.0%+14.9%
P/E Ratio57.8828.1131.19

Revenue Estimates

PeriodLowAvgHigh#
2026-07-31$90M$90M$90M1
2026-10-31$126M$126M$126M1
2027-01-31$137M$137M$137M1
2027-04-30$154M$154M$155M1

EPS Estimates

PeriodLowAvgHigh#
2026-07-31$-0.07$-0.07$-0.071
2026-10-31$0.06$0.06$0.061
2027-01-31$0.09$0.09$0.091
2027-04-30$0.23$0.23$0.231

Frequently Asked Questions

What is the analyst consensus for SWBI?

The consensus among 1 analysts covering Smith & Wesson Brands, Inc. (SWBI) is Buy with an average price target of $15.25.

What is the highest price target for SWBI?

The highest price target for SWBI is $18.00, set by Mark Smith at Lake Street on 2024-06-21.

What is the lowest price target for SWBI?

The lowest price target for SWBI is $18.00, set by Mark Smith at Lake Street on 2024-06-21.

How many analysts cover SWBI?

1 analysts have issued ratings for Smith & Wesson Brands, Inc. in the past 12 months.

Is SWBI a buy or sell right now?

Based on 1 analyst ratings, SWBI has a consensus rating of Buy (2.00/5) with a -2.1% upside to the consensus target of $15.25.

What are the earnings estimates for SWBI?

Analysts estimate SWBI will report EPS of $-0.07 for the period ending 2026-07-31, with revenue estimated at $90M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.